tiprankstipranks
Replimune Group (REPL)
NASDAQ:REPL
US Market
REPL
Replimune Group
RESEARCH TOOLSreports
Want to see REPL full AI Analyst Report?

Replimune Group (REPL) Stock News & Sentiment

518 Followers
Why Penny Stock Replimune (REPL) Nearly Doubled Today
Premium
Market News
Why Penny Stock Replimune (REPL) Nearly Doubled Today
9d ago
BMY
REPL
Replimune to Resubmit Priority FDA Filing for RP1
Premium
Company Announcements
Replimune to Resubmit Priority FDA Filing for RP1
9d ago
8K
REPL
REPL Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
REPL Earnings this Week: How Will it Perform?
26d ago
REPL
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
Premium
Market News
Why Is Vanguard Total Stock Market ETF (VTI) Down Today, 4/13/2026?
2M ago
IMA
VTI
Replimune: Binary RP1 PDUFA Outcome and Funding Overhang Justify Hold Rating
Premium
Ratings
Replimune: Binary RP1 PDUFA Outcome and Funding Overhang Justify Hold Rating
3M ago
REPL
Replimune amends Hercules loan, strengthens funding runway
Premium
Company Announcements
Replimune amends Hercules loan, strengthens funding runway
4M ago
8K
REPL
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
Premium
Company Announcements
Replimune Highlights RP1, RP2 Progress Ahead of JPM Conference
5M ago
8K
REPL
More REPL News >

REPL News on the Web

Acting FDA head vows to block political interference, Endpoint News says
TipRanks News
Neutral
Insider Sell: Christopher Sarchi Sells 12,000 Shares of Replimune Group Inc (REPL)
GuruFocus News
Bearish
Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL), Eli Lilly & Co (LLY) and Relay Therapeutics (RLAY)
TipRanks News
Bearish
Top Biotech Gainers: REPL On Track, SNSE Awaits Phase 2 Data, Keep An Eye On CCCC, IMRX Soars
rttnews
Bullish
Replimune presents final first-in-human data for RP2 alone, with nivolumab
TipRanks News
Bullish
Replimune presents 3-year overall survival data from IGNYTE trial
TipRanks News
Bullish
Replimune's IGNYTE Trial Shows Durable Survival Benefit
rttnews
Bullish
Replimune (REPL) Gains FDA Support for RP1 Resubmission
GuruFocus News
Bullish

News Score - Last 7 Days

Positive
REPL
Sector Average
Media Buzz
This Week7 articles
Weekly Average6 articles
News Sentiment
This Week59%
Sector Average82%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is REPL’s Media Buzz Sentiment?
7 articles about REPL were published this week. In an average week, 6 articles are published.
    What is REPL’s weekly average amount of articles?
    In an average week, 6 articles about REPL are published.
      What is REPL’s News Sentiment?
      59% of articles about REPL were positive this week, compared to its sector average of 82%.
        Healthcare Stocks that are Trending in the News
        VEEVVeeva Systems
        MDTMedtronic
        FULCFulcrum Therapeutics
        RZLTRezolute
        9926Akeso, Inc.
        Showing the stocks with the most bullish news sentiment over the past week